P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY

Authors :: K. Groen
C. Stege
K. Nasserinejad
K. de Heer
R. van Kampen
R. Leys
N. Thielen
M. Westerman
K. Wu
I. Ludwig
D. Issa
G. Velders
M. Vekemans
N. van de Donk
G. Timmers
F. de Boer
L. Tick
E. van der Spek
E. de Waal
M. Sohne
P. Sonneveld
I. Nijhof
S. Klein
M. Levin
P. Ypma
S. Zweegman
Source :: HemaSphere. 7:16-17
Publication Year :: 2023
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2023.

Full Text Access

Tools